Oxochromium(V) species formed with 2,3-dehydro-2-deoxy-N-acetylneuraminic or N-acetylneuraminic (sialic) acids: An in vitro model system of oxochromium(V) species potentially stabilized in the respiratory tract upon inhalation of carcinogenic chromium(VI) compounds

Chemical Research in Toxicology

Volumn 16, Issue 7, 2003, Pages 881-892

  Codd, Rachel ^a   Lay, Peter A ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CHROMIUM; GLUTATHIONE; LIGAND; N ACETYL 2,3 DIDEHYDRO 2 DEOXYNEURAMINIC ACID; N ACETYLNEURAMINIC ACID; NEURAMINIC ACID DERIVATIVE; OXOCHROMIUM; SIALIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CHEMICAL CARCINOGENESIS; CHEMICAL STRUCTURE; DNA DAMAGE; ELECTRON SPIN RESONANCE; GENOTOXICITY; HUMAN; IN VITRO STUDY; INHALATION; LUNG CANCER; LUNG CARCINOGENESIS; MODEL; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; RESPIRATORY TRACT CANCER;

EID: 0041307008     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx034077n     Document Type: Article

References (56)

1. IARC (1990) Chromium, nickel and welding. In IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 49, pp 127-198, International Agency for Research on Cancer, Lyon, France.
2. Pellerin, C., and Booker, S. M. (2000) Reflections on hexavalent chromium. Environ. Health Perspect. 108, A402-A407.
3. Gibb, H. J., Lees, P. S. J., Pinsky, P. F., and Rooney, B. C. (2000) Lung cancer among workers in chromium chemical production. Am. J. Ind. Med., 115-126.
4. Levina, A., Codd, R., Dillon, C. T., and Lay, P. A. (2003) Chromium in biology: toxicology and nutritional aspects. Prog. Inorg. Chem. 51, 145-250.
5. Farrell, R. P., Judd, R. J., Lay, P. A., Dixon, N. E., Baker, R. S. U., and Bonin, A. M. (1989) Chromium(V)-induced cleavage of DNA: are chromium(V) complexes the active carcinogens in chromium(VI)-induced cancers? Chem. Res. Toxicol. 2, 227-229.
6. Levina, A., Barr-David, R., Codd, R., Lay, P. A., Dixon, N. E., Hammershoi, A., and Hendry, P. (1999) In vitro plasmid DNA cleavage by chromium(V) and -(IV) 2-hydroxycarboxylato complexes. Chem. Res. Toxicol. 12, 371-381.
7. Levina, A., Lay, P. A., and Dixon, N. E. (2000) Disproportionation and nuclease activity of bis[2-ethyl-2-hydroxybutanoato(2-)]oxochromate(V) in neutral aqueous solutions. Inorg. Chem. 39, 385-395.
8. Dillon, C. T., Lay, P. A., Bonin, A. M., Cholewa, M., and Legge, G. J. F. (2000) Permeability, cytotoxicity and genotoxicity of Cr(III) complexes and some Cr(V) analogues in V79 Chinese hamster lung cells. Chem. Res. Toxicol. 13, 742-748.
9. Dillon, C. T., Lay, P. A., Bonin, A. M., Dixon, N. E., and Sulfab, Y. (2000) DNA interactions and bacterial mutagenicity of some chromium(III) imine complexes and their chromium(V) analogues. Evidence for chromium(V) intermediates in the genotoxicity of chromium(III). Aust. J. Chem. 53, 411-424.
10. Barr-David, G., Charara, M., Codd, R., Farrell, R. P., Irwin, J. A., Lay, P. A., Bramley, R., Brumby, S., Ji, J.-Y., and Hanson, G. R. (1995) EPR characterisation of the Cr(V) intermediates in the Cr(VI)/Cr(V) oxidations of organic substrates and of relevance to Cr-induced cancers. J. Chem. Soc., Faraday Trans. 91, 1207-1216.
11. Codd, R., Irwin, J. A., and Lay, P. A. (2003) Sialoglycoprotein and carbohydrate complexes in chromium toxicity. Curr. Opin. Chem. Biol. 7, 213-219.
12. Rizzotto, M., Levina, A., Santoro, M., Garcia, S., Frascaroli, M. I., Signorella, S., Sala, L. F., and Lay, P. A. (2002) Redox and ligand-exchange chemistry of chromium(VI/V)-methyl glycoside systems. J. Chem. Soc., Dalton Trans., 3206-3213.
13. Codd, R., and Lay, P. A. (1999) Competition between 1,2-diol and 2-hydroxy acid coordination in Cr(V)-quinic acid complexes: implications for stabilization of Cr(V) intermediates of relevance to Cr(VI)-induced carcinogenesis. J. Am. Chem. Soc. 121, 7864-7876.
14. Angata, T., and Varki, A. (2002) Chemical diversity in the sialic acids and related a-keto acids: an evolutionary perspective. Chem. Rev. 102, 439-469.
15. Traving, C., and Schauer, R. (1998) Structure, function and metabolism of sialic acids. Cell. Mol. Life Sci. 54, 1330-1349.
16. Codd, R., and Lay, P. A. (2001) Chromium(V)-sialic (neuraminic) acid species are formed from mixtures of chromium(VI) and saliva. J. Am. Chem. Soc. 123, 11799-11800.
17. Corfield, A. P., and Schauer, R. (1982) Occurrence of Sialic Acids. In Sialic Acids. Chemistry, Metabolism and Function (Schauer, R., Ed.) Vol. 10, pp 5-50, Springer-Verlag, Vienna.
18. Schauer, R., Kelm, S., Reuter, G., Roggentin, P., and Shaw, L. (1995) Biochemistry and role of sialic acids. In Biology of the Sialic Acids (Rosenberg, A., Ed.) pp 7-67, Plenum Press, New York.
19. Burmeister, W. P., Ruigrok, R. W. H., and Cusack, S. (1992) The 2.2 Å resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. EMBO J. 11, 49-56.
20. Kiefel, M. J., and von Itzstein, M. (2002) Recent advances in the synthesis of sialic acid derivatives and sialylmimetics as biological probes. Chem. Rev. 102, 471-490.
21. von Itzstein, M., Wu, W.-Y., and Jin, B. (1994) The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: a potent influenza virus sialidase inhibitor. Carbohydr. Res. 259, 301-305.
22. Sillanaukee, P., Pönniö, M., and Jääskeläinen, I. P. (1999) Occurrence of sialic acids in healthy humans and different disorders. Eur. J. Clin. Invest. 29, 413-425.
23. Jaques, L. W., Brown, E. B., Barrett, J. M., Brey, J. W. S., and Weltner, J. W. (1977) Sialic acid. A calcium-binding carbohydrate. J. Biol. Chem. 252, 4533-4538.
24. Jaques, L. W., Riesco, B. F., and Weltner, W. J. (1980) NMR spectroscopy and calcium binding of sialic acids: N-glycolylneuraminic acid and periodate-oxidized N-acetylneuraminic acid. Carbohydr. Res. 83, 21-32.
25. Saladini, M., Menabue, L., and Ferrari, E. (2002) Binding ability of sialic acid towards biological and toxic metal ions. NMR, potentiometric and spectroscopic study. J. Inorg. Biochem. 88, 61-68.
26. Dillon, C. T., Lay, P. A., Bonin, A. M., Cholewa, M., Legge, G. J. F., Collins, T. J., and Kostka, K. L. (1998) Permeability, cytotoxicity, and genotoxicity of chromium(V) and chromium(VI) complexes in V79 chinese hamster lung cells. Chem. Res. Toxicol. 11, 119-129.
27. Duling, D. R. (1994) Simulation of multiple isotropic spin-trap EPR spectra. J. Magn. Reson. B104, 105-110.
28. WinSIM (1995) EPR Calculations for MS-Windows, Version 0.96, National Institute of Environmental Health Sciences.
29. Codd, R., Dillon, C. T., Levina, A., and Lay, P. A. (2001) Studies on the genotoxicity of chromium: from the test tube to the cell. Coord. Chem. Rev. 216-217, 533-577.
30. Aiyar, J., Borges, K. M., Floyd, R. A., and Wetterhahn, K. E. (1989) Role of chromium(V), glutathione thiyl radical and hydroxyl radical intermediates in chromium(VI)-induced DNA damage. Toxicol. Environ. Chem. 22, 135-148.
31. Levina, A., Zhang, L., and Lay, P. A. (2003) Structure and reactivity of a chromium(V) glutathione complex. Inorg. Chem. 42, 767-784.
32. Connett, P. H., and Wetterhahn, K. E. (1985) In vitro reaction of the carcinogen chromate with cellular thiols and carboxylic acids. J. Am. Chem. Soc. 107, 4282-4288.
33. Bramley, R., Ji, J.-Y., and Lay, P. A. (1991) Ligand-exchange reactions of chromium(V): characterization of the ligand-exchange equilibria of bis(2-ethyl-2-hydroxybutanoato(2-))oxochromate(V) in aqueous 1,2-ethanediol and the solution structure of bis(1,2-ethanediolato(2-))oxochromate(V). Inorg. Chem. 30, 1557-1564.
34. Headlam, H. A., and Lay, P. A. (2001) EPR spectroscopic studies of the reduction of chromium(VI) by methanol in the presence of peptides. Formation of long-lived chromium(V) peptides complexes. Inorg. Chem. 40, 78-86.
35. a value of I, elative to II, is most likely due to the increased delocalization of the negative charge in II over the α-keto or the α-hemiacetal group (40).
36. Codd, R., Levina, A., Zhang, L., Hambley, T. W., and Lay, P. A. (2000) Characterization and X-ray absorption spectroscopic studies of bis[quinato(2-)]oxochromate(V). Inorg. Chem. 39, 990-997.
37. Bramley, R., Ji, J.-Y., Judd, R. J., and Lay, P. A. (1990) Solvent dependence of the EPR spectra of oxochromate(V) complexes: solution structures and the effects of hydrogen bonding between the solvent and the complex. Inorg. Chem. 29, 3089-3094.
38. Krumpolĉ, M., DeBoer, B. G., and Rocek, J. (1978) A stable chromium(V) compound. Synthesis, properties, and crystal structure of potassium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) monohydrate. J. Am. Chem. Soc. 100, 145-153.
39. Judd, R. J., Hambley, T. W., and Lay, P. A. (1989) Electrochemistry of the quasireversible bis[2-ethyl-2-hydroxybutanoato(2-)]oxochromate(V) and -(IV) and bis[2-hydroxy-2-methylbutanoato(2-)]oxochromate(V) and -(IV) redox couples and the crystal and molecular structure of sodium bis[2-ethyl-2-hydroxybutanoato(2-)]-oxochromate(V) sesquihydrate. J. Chem. Soc., Dalton Trans., 2205-2210.
40. Hurd, C. D. (1970) The acidities of ascorbic and sialic acids. J. Chem. Educ. 47, 481-482.
41. Friebolin, H., Schmidt, H., and Supp, M. (1981) Proton NMR study of sialinic acids. Part 3. Labeling of N-acetyl-D-neuraminic acid with deuterium. Tetrahedron Lett. 22, 5171-5174.
42. -. Eur. J. Inorg. Chem., 1829-1833.
43. Gottschalk, A. (1955) 2-Carboxypyrrole: its preparation from and its precursor in mucoproteins. Biochem. J. 61, 298-307.
44. Castells, M. T., Ballesta, J., Pastor, L. M., Madrid, J. F., and Marin, J. A. (1990) Histochemical characterisation of glycoconjugates in the epithelium of the extrapulmonary airways of several vertabrates. Histochem. J. 22, 24-35.
45. Washington, N., Steele, R. J. C., Jackson, S. J., Bush, D., Mason, J., Gill, D. A., Pitt, K., and Rawlins, D. A. (2000) Determination of baseline human nasal pH and the effect of intranasally administered buffers. Int. J. Pharm. 198, 139-146.
46. Westerveld, G.-J., Dekker, I., Voss, H.-P., Bast, A., and Scheeren, R. A. (1997) Antioxidant levels in the nasal mucosa of patients with chromic sinusitis and healthy controls. Arch. Otolaryngol. 123, 201-204.
47. 1H NMR studies at N-acetyl-D-neuraminic acid ketosides for the determination of the anomeric configuration II. Tetrahedron Lett. 20, 4637-4640.
48. Flippen, J. L. (1973) The crystal structure of β-D-N-acetylneuraminc acid dihydrate (sialic acid). Acta Crystallogr., Sect. B B29, 1881-1886.
49. Furuhata, K., Sato, S., Goto, M., Takayanagi, H., and Ogura, H. (1988) Studies on sialic acids. VII. The crystal and molecular structure of N-acetyl-2,3-dehydro-2-deoxyneuraminic acid. Chem. Pharm. Bull. 36, 1872-1876.
50. Czarniecki, M. F., and Thornton, E. R. (1976) Carbon-13 spin lattice relaxation in the neuraminic acids. Evidence for an unusual intramolecular hydrogen bonding network. J. Am. Chem. Soc. 98, 1023-1025.
51. Brown, E. B., Brey, W. S., Jr., and Weltner, W., Jr. (1975) Cell-surface carbohydrates and their interactions. 1. NMR of N-acetylneuraminic acid. Biochim. Biophys. Acta 399, 124-130.
52. O'Connell, A. M. (1973) The crystal structure of N-acetylneuraminic acid methyl ester monohydrate. Acta Crystallogr., Sect. B B29, 2320-2328.
53. Branca, M., Dessi, A., Micera, G., and Sanna, D. (1993) EPR and proton ENDOR study of the solution equilibria of bis(2-ethyl-2hydroxybutanoato(2-))oxochromate(V) and bis(2-hydroxy-2-methylbutanoato(2-))oxochromate(V). Inorg. Chem. 32, 578-581.
54. Pool-Zobel, B. L., Lotzmann, N., Knoll, M., Kuchenmeister, F., Lambertz, R., Leucht, U., Schröder, H.-G., and Schmezer, P. (1994) Detection of genotoxic effects in human gastric and nasal mucosa cells isolated from biopsy samples. Environ. Mol. Mutagen. 24, 24-45.
55. Shrivastava, H. Y., and Nair, B. U. (2000) Cleavage of human orosomucoid by a chromium(V) species: relevance in biotoxicity of chromium. Biochem. Biophys. Res. Commun. 279, 980-983.
56. Shrivastava, H. Y., Dhathathreyan, A., and Nair, B. U. (2003) Insight into structural transition, aggregation and folding of glycoprotein in the presence of chromium(III) complexes by spectroscopic, microscopic and kinetic studies. Chem. Phys. Lett. 369, 534-540.